Valuation StemRIM

Stocks

Market Closed - Japan Exchange 10:30:00 04/11/2026 +04			5-day change	1st Jan Change
130.00 ^JPY	-2.99%		-9.09%	-50.57%

10-07	StemRIM Inc. Announces Patent Registration for Stem Cell Gene Therapy Technology SR-GT1 Aimed at Curative Treatment of Dystrophic Epidermolysis Bullosa in USA	CI
09-25	StemRIM Inc. Announces Patent Registration In South Korea For Use Of Redasemtide As Additional Therapeutic Indication Of Cartilage Disorders	CI

Data adjusted to current consolidation scope

Fiscal Period: July	2020	2021	2022	2023	2024	2025
Market Cap ¹	46,285	39,013	49,873	56,361	27,624	19,759
Change	-	-15.71%	27.84%	13.01%	-50.99%	-28.47%
Enterprise Value (EV) ¹	35,618	28,847	40,996	46,144	19,214	12,765
Change	-	-19.01%	42.12%	12.56%	-58.36%	-33.56%
P/E	143x	-66.2x	-25.5x	344x	-13.6x	-10.2x
PBR	4.25x	3.65x	5.3x	5.44x	3.11x	2.7x
PEG	-	0x	-0x	-3x	0x	1.85x
Capitalization / Revenue	22x	27.9x	2,267x	24x	-	-
EV / Revenue	17x	20.6x	1,863x	19.6x	-	-
EV / EBITDA	84.2x	-52.4x	-21.2x	243x	-9.46x	-6.64x
EV / EBIT	85.6x	-48.6x	-20.7x	323x	-9.26x	-6.48x
EV / FCF	129x	-40.1x	-32.5x	104x	-11.6x	-11.9x
FCF Yield	0.77%	-2.49%	-3.08%	0.96%	-8.6%	-8.38%
Dividend per Share ²	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-
EPS ²	5.74	-10.02	-32.91	2.69	-32.98	-31.16
Distribution rate	-	-	-	-	-	-
Net sales ¹	2,100	1,400	22	2,350	-	-
EBITDA ¹	423	-550	-1,932	190	-2,032	-1,922
EBIT ¹	416	-593	-1,981	143	-2,076	-1,971
Net income ¹	347	-582	-1,948	168	-2,022	-1,929
Net Debt ¹	-10,667	-10,166	-8,877	-10,217	-8,410	-6,994
Reference price ²	820.00	663.00	840.00	926.00	449.00	318.00
Nbr of stocks (in thousands)	56,445	58,843	59,373	60,864	61,523	62,136
Announcement Date	29/10/20	28/10/21	27/10/22	26/10/23	31/10/24	21/10/25

¹JPY in Million²JPY

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
STEMRIM	-	-	-	-	53M
ELI LILLY AND COMPANY	41.24x	13.94x	30.97x	0.48%	1,255B
JOHNSON & JOHNSON	38.96x	6.55x	18.42x	2.01%	641B
ABBVIE INC.	36.79x	8.37x	17.26x	2.42%	505B
ROCHE HOLDING AG	21.08x	5.12x	12.75x	2.56%	381B
MERCK & CO., INC.	95.75x	5.88x	25.02x	2.35%	357B
NOVARTIS AG	22.88x	5.88x	14.19x	2.73%	303B
ASTRAZENECA PLC	24.26x	4.85x	13.68x	1.8%	286B
AMGEN INC.	29.25x	7.46x	13.36x	2.19%	249B
GILEAD SCIENCES, INC.	-40.09x	7.32x	45.96x	1.97%	208B
Average	30.01x	7.26x	21.29x	2.06%	418.53B
Weighted average by Cap.	35.93x	8.73x	22.53x	1.73%